WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today reminds that CEO Dr. Ryan Saadi MD, MPH will participate in BioNJ’s Fifteenth ...
Tevogen Bio announced Jan. 28 it entered an agreement with KRHP LLC. The accord means the Warren-headquartered clinical-stage specialty immunotherapy biotechnology company, which NJBIZ has previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results